Shanghai-based anti-bacterial company Phagelux, Inc., has raised US$10 million financing with undisclosed investors, according to a company announcement. "This round of financing will be instrumental in moving our development programs forward, acquiring some additional assets, and even starting to commercialize our first programs," says Mark Engel, chairman of Phagelux. Phagelux develops anti-bacterial solutions for crop […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network